Surgical treatment of infective endocarditis

Stinson, Edward B.

doi:10.1016/0033-0620(79)90020-3

Cited by 129 publications

(50 citation statements)

References 100 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Despite a higher operative mortality rate in patients with CHF than in those without CHF, patients with IE who have CHF and undergo valve surgery have a substantially reduced mortality rate compared with those treated with medical therapy alone. 212 The incidence of reinfection of newly implanted valves in patients with active IE is Ϸ2% to 3% 213,214 and is far less than the mortality rate for IE and CHF without surgical therapy, which can be as high as 51%. 212 Surgical approaches to CHF caused by different mechanisms are discussed in the section on CHF.…”

Section: Complications and Their Treatment Surgical Therapymentioning

confidence: 99%

“…[212][213][214][215] Moderate to severe CHF was identified as 1 of 5 baseline features that were independently associated with 6-month mortality in an investigation 216 to validate a prognostic classification system for adults with complicated left-sided native valve IE. In native valve IE, acute CHF occurs more frequently in aortic valve infections (29%) than with mitral (20%) or tricuspid disease (8%).…”

Section: Congestive Heart Failurementioning

confidence: 99%

“…212 CHF in IE, irrespective of the course or mechanism, portends a grave prognosis with medical therapy alone and also is the most powerful predictor of poor outcome with surgical therapy. 214 Echocardiographic evaluation of IE patients delineates the causes and severity of CHF. Ventricular size, wall motion, and dynamic function can be readily defined and valve insufficiency quantified.…”

Section: Congestive Heart Failurementioning

confidence: 99%

See 2 more Smart Citations

Infective Endocarditis

Baddour¹,

Wilson²,

Bayer³

et al. 2005

Circulation

1,274

436

View full text Add to dashboard Cite

Background-Despite advances in medical, surgical, and critical care interventions, infective endocarditis remains a disease that is associated with considerable morbidity and mortality. The continuing evolution of antimicrobial resistance among common pathogens that cause infective endocarditis creates additional therapeutic issues for physicians to manage in this potentially life-threatening illness. Methods and Results-This work represents the third iteration of an infective endocarditis "treatment" document developed by the American Heart Association under the auspices of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease of the Young. It updates recommendations for diagnosis, treatment, and management of complications of infective endocarditis. A multidisciplinary committee of experts drafted this document to assist physicians in the evolving care of patients with infective endocarditis in the new millennium. This extensive document is accompanied by an executive summary that covers the key points of the diagnosis, antimicrobial therapy, and management of infective endocarditis. For the first time, an evidence-based scoring system that is used by the American College of Cardiology and the American Heart Association was applied to treatment recommendations. Tables also have been included that provide input on the use of echocardiography during diagnosis and treatment of infective endocarditis, evaluation and treatment of culture-negative endocarditis, and short-term and long-term management of patients during and after completion of antimicrobial treatment. To assist physicians who care for children, pediatric dosing was added to each treatment regimen. Conclusions-The recommendations outlined in this update should assist physicians in all aspects of patient care in the diagnosis, medical and surgical treatment, and follow-up of infective endocarditis, as well as management of associated complications. Clinical variability and complexity in infective endocarditis, however, dictate that these guidelines be used to support and not supplant physician-directed decisions in individual patient management. (Circulation. 2005; 111:e394-e433.)

show abstract

Section: Complications and Their Treatment Surgical Therapymentioning

confidence: 99%

Section: Congestive Heart Failurementioning

confidence: 99%

Section: Congestive Heart Failurementioning

confidence: 99%

See 1 more Smart Citation

Infective Endocarditis

Baddour¹,

Wilson²,

Bayer³

et al. 2005

Circulation

1,274

436

View full text Add to dashboard Cite

show abstract

“…81 CHF in IE, irrespective of the course or mechanism, portends a grave prognosis with medical therapy alone and is also the most powerful predictor of poor outcome with surgical therapy. 82 Delaying surgery to the point of frank ventricular decompensation dramatically increases operative mortality, from 6% to 11% for patients without CHF and 17% to 33% for patients with CHF. 83,84 Echocardiographic evaluation of IE patients delineates the causes and severity of CHF.…”

Section: Congestive Heart Failurementioning

confidence: 99%

“…28,102 Periannular extension is common, occurring in 10% to 40% of all native-valve IE, and complicates aortic IE more commonly than mitral or tricuspid IE. 82,103,104 Periannular infection is of even greater concern with prosthetic-valve IE, occurring in 56% to 100% of patients. 102 Perivalvular abscesses are particularly common with prosthetic valves because the annulus, rather than the leaflet, is the usual primary site of infection.…”

Section: Periannular Extension Of Infectionmentioning

confidence: 99%